Provectus Biopharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2008 | — | — | $2.8M |
| FY2009 | — | — | $3.2M |
| FY2010 | $3.7M | $14.4M | $8.1M |
| FY2011 | $3.3M | $13.3M | $7.7M |
| FY2012 | $1.8M | $6.2M | $1.2M |
| FY2013 | $13.4M | $20.0M | $15.7M |
| FY2014 | $994.3K | $26.2M | $17.4M |
| FY2015 | $4.1M | $20.4M | $14.2M |
| FY2016 | $2.1M | $5.6M | $1.2M |
| FY2017 | $13.5M | $3.4M | $105.5K |
| FY2018 | $19.4M | $2.0M | $51.0K |
| FY2019 | $25.5M | $1.5M | $590.7K |
| FY2020 | $30.8M | $589.2K | $97.2K |
| FY2021 | $7.7M | $3.5M | $683.0K |
| FY2022 | $8.3M | $2.0M | $21.6K |
| FY2023 | $9.0M | $1.4M | $76.6K |
| FY2024 | $7.0M | $1.0M | $307.4K |
| FY2025 | $7.0M | $697.5K | $251.3K |